Andrew P Gard1, Brian D Sayles2, J Will Robbins2, William E Thorell2, Daniel L Surdell2. 1. Division of Neurosurgery, University of Nebraska Medical Center, 982035 Nebraska Medical Center, Omaha, NE, 68198-2035, USA. apgard@unmc.edu. 2. Division of Neurosurgery, University of Nebraska Medical Center, 982035 Nebraska Medical Center, Omaha, NE, 68198-2035, USA.
Abstract
OBJECTIVE: The use of antiplatelet or anticoagulants has previously been shown to increase hemorrhagic complications of ventricular catheterization. Although heparin use 24 h after ventriculostomy appears safe, the safety of heparin immediately (within 4 h) after ventriculostomy is unknown. The objective of this study was to assess the safety of heparin immediately (within 4 h) after ventriculostomy in subarachnoid hemorrhage (SAH) patients undergoing endovascular treatment. PATIENTS AND METHODS: This is a retrospective cohort study of 46 patients with aneurysmal SAH secondary to aneurysm rupture who required ventriculostomy. Post-ventriculostomy imaging was carefully reviewed for tract hemorrhaging. Timing of heparinization was noted. Early heparinization was within 4 h after ventriculostomy, and intermediate heparinization was between 4 and 24 h after ventriculostomy. RESULTS: Overall, the tract hemorrhage rate was 26.1% for the study cohort-mostly grade I tract hemorrhages-consistent with the existing literature. The tract hemorrhage rate in the early (<4 h) heparin group was a remarkable 58.8%. The hemorrhages were also notably larger in the early (<4 h) heparin group. CONCLUSION: Although heparin appears to be safe after 4 h, immediate heparinization (within 4 h) after ventriculostomy significantly increases the odds of tract hemorrhage. Additional time should be afforded between ventriculostomy and heparinization to avoid potentially devastating external ventricular drain tract hemorrhage. It is advisable to wait a sufficient time (at least 4 h) after ventriculostomy before embarking on endovascular treatment of ruptured aneurysms.
OBJECTIVE: The use of antiplatelet or anticoagulants has previously been shown to increase hemorrhagic complications of ventricular catheterization. Although heparin use 24 h after ventriculostomy appears safe, the safety of heparin immediately (within 4 h) after ventriculostomy is unknown. The objective of this study was to assess the safety of heparin immediately (within 4 h) after ventriculostomy in subarachnoid hemorrhage (SAH) patients undergoing endovascular treatment. PATIENTS AND METHODS: This is a retrospective cohort study of 46 patients with aneurysmalSAH secondary to aneurysm rupture who required ventriculostomy. Post-ventriculostomy imaging was carefully reviewed for tract hemorrhaging. Timing of heparinization was noted. Early heparinization was within 4 h after ventriculostomy, and intermediate heparinization was between 4 and 24 h after ventriculostomy. RESULTS: Overall, the tract hemorrhage rate was 26.1% for the study cohort-mostly grade I tract hemorrhages-consistent with the existing literature. The tract hemorrhage rate in the early (<4 h) heparin group was a remarkable 58.8%. The hemorrhages were also notably larger in the early (<4 h) heparin group. CONCLUSION: Although heparin appears to be safe after 4 h, immediate heparinization (within 4 h) after ventriculostomy significantly increases the odds of tract hemorrhage. Additional time should be afforded between ventriculostomy and heparinization to avoid potentially devastating external ventricular drain tract hemorrhage. It is advisable to wait a sufficient time (at least 4 h) after ventriculostomy before embarking on endovascular treatment of ruptured aneurysms.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Richard C E Anderson; Peter Kan; Paul Klimo; Douglas L Brockmeyer; Marion L Walker; John R W Kestle Journal: J Neurosurg Date: 2004-08 Impact factor: 5.115
Authors: Eric S Sussman; Christopher P Kellner; Eric Nelson; Michael M McDowell; Samuel S Bruce; Rachel A Bruce; Zong Zhuang; E Sander Connolly Journal: J Neurosurg Date: 2014-01-10 Impact factor: 5.115
Authors: David K Kung; Bruno A Policeni; Ana W Capuano; James D Rossen; Pascal M Jabbour; James C Torner; Matthew A Howard; David Hasan Journal: J Neurosurg Date: 2010-10-15 Impact factor: 5.115
Authors: Matthew B Maas; Babak S Jahromi; Ayush Batra; Matthew B Potts; Andrew M Naidech; Eric M Liotta Journal: Stroke Date: 2020-08-10 Impact factor: 7.914
Authors: Edgar A Samaniego; Emilee Gibson; Daichi Nakagawa; Santiago Ortega-Gutierrez; Mario Zanaty; Jorge A Roa; Pascal Jabbour; David M Hasan Journal: Stroke Vasc Neurol Date: 2019-02-03
Authors: Moritz Lenschow; Niklas von Spreckelsen; Sergej Telentschak; Christoph Kabbasch; Roland Goldbrunner; Stefan Grau Journal: Neurosurg Rev Date: 2022-04-29 Impact factor: 2.800